Hydroxycarbamide
UK matches:
- HYDROXYCARBAMIDE 500 MG CAPSULES HARD (Leaflet)
- HYDROXYCARBAMIDE 500MG CAPSULES HARD (Leaflet)
- HYDROXYCARBAMIDE MEDAC 500MG CAPSULE HARD (Leaflet)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XX05
CAS registry number (Chemical Abstracts Service)
0000127-07-1
Chemical Formula
C-H4-N2-O2
Molecular Weight
76
Therapeutic Category
Cytostatic agent
Chemical Names
Carbamohydroxamic acid
Carbamohydroximic acid
Carbamoyl oxime
Carbamyl hydroxamate
Hydroxylamine, N-(aminocarbonyl)-
Hydroxylamine, N-carbamoyl-
Hydroxyurea (WHO)
N-Carbamoylhydroxylamine
N-Hydroxyharnstoff (IUPAC)
N-Hydroxymocovina
Urea, hydroxy- (USAN)
Foreign Names
- Hydroxycarbamidum (Latin)
- Hydroxycarbamid (German)
- Hydroxycarbamide (French)
- Hidroxicarbamida (Spanish)
Generic Names
- Hydroxycarbamide (OS: DCF, BAN)
- Hydroxyurea (OS: USAN)
- Idroxicarbamide (OS: DCIT)
- 4-03-00-00170 (IS: Beilstein)
- AI3-51139 (IS)
- BRN 1741548 (IS)
- CCRIS 958 (IS)
- EINECS 204-821-7 (IS)
- HSDB 6887 (IS)
- NCI-C04831 (IS)
- NSC 32065 (IS)
- SK 22591 (IS)
- SQ 1089 (IS)
- Hydroxycarbamid (PH: Ph. Eur. 7)
- Hydroxycarbamide (PH: BP 2011, Ph. Eur. 7)
- Hydroxycarbamidum (PH: Ph. Eur. 7)
- Hydroxyurea (PH: USP 34)
Brand Names
- Apo-Hydroxyurea
Apotex, Canada; Apotex, Hong Kong - Droxamida
AC Farma, Peru - Droxia
Bristol-Myers Squibb, United States - Hidroksikarbamid
Habit, Serbia - Hidroxcarbamida Kampar
Kampar, Chile - Hidroxiurea Asofarma
Raffo, Argentina - Hidroxiurea Delta Farma
Delta Farma, Argentina - Hidroxiurea Dosa
Dosa, Argentina - Hidroxiurea Filaxis
Filaxis, Argentina - Hidroxiurea Lafedar
Lafedar, Argentina - Hidroxiurea Martian
LKM, Argentina - Hidroxiurea Microsules
Microsules, Argentina - Hidroxiurea Rontag
Rontag, Argentina - Hidroxiurea
Pharmaceutical, Venezuela - Hondrea
Alkem, India - Hydab
Fresenius, Philippines - Hydrea
Bristol Myers Squibb, Spain; Bristol Myers Squibb, Latvia; Bristol-Myers Squibb, United Arab Emirates; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Bulgaria; Bristol-Myers Squibb, Bahrain; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Egypt; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Georgia; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Indonesia; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Iraq; Bristol-Myers Squibb, Iran; Bristol-Myers Squibb, Jordan; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, Kuwait; Bristol-Myers Squibb, Lebanon; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Luxembourg; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Qatar; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Saudi Arabia; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Syria; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, Tunisia; Bristol-Myers Squibb, Turkey; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, Yemen; Bristol-Myers Squibb, South Africa; Corden Pharma, Estonia; Medicines Group, New Zealand; Orifarm, Norway; P & D, Malta - Hydréa
Bristol-Myers Squibb, France - Hydreasyn
FarmaSyn, Greece - Hydrine
Meizler, Brazil - Hydrox
Cipla, Philippines - Hydroxycarbamid HEXAL
Hexal, Germany - Hydroxycarbamid Pliva
Pliva, Poland - Hydroxycarbamide medac
medac, United Kingdom - Hydroxycarbamide
Pliva, Lithuania - Hydroxycarbamide-Jialin Pharm
Jialin, China - Hydroxyurea Medac
Medac, Denmark; Medac, Sweden - Hydroxyurea medac
medac, Austria - Hydroxyurea
Par, United States; Pliva Pliva Hrvatska, Russian Federation; Roxane, United States; Teva, United States - Hytinon
Korea United Pharm, Vietnam - Krabinex
Korea United Pharma, Philippines - Leukocel
Celon, India - Litalir
Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Bosnia & Herzegowina; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Serbia; Bristol-Myers Squibb, Slovenia; Bristol-Myers Squibb, Slovakia; PharmaSwiss, Croatia (Hrvatska) - Onco-Carbide
Teofarma, Italy - Oxyrea
Cadila, India - Rexinth
Richmond, Argentina - Siklos
Addmedica, France; Addmedica, Greece; Addmedica, Lithuania; Addmedica, Luxembourg; Nordic Pharma, Germany; Nordic Pharma, United Kingdom; Nordic Pharma, Netherlands; Rovi, Spain - Syrea
medac, Germany - Urdox
Zydus, India
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.


